Trade name

MEDRx Co., Ltd

Stock market

Growth Market of the Tokyo Stock Exchange (since 2013)

Stock code

4586

Establishment

January, 2002

Head office

431-7 Nishiyama Higashikagawa-city, Kagawa, Japan
769-2712
TEL: +81-879-23-3071
FAX: +81-879-23-3072

Tokyo office

Shimazuru Build. 2F, 2-35-7 Hama-cho, Nihonbashi, Chuou-ku, Tokyo, Japan 103-0007
TEL：+81-3-3664-9630
FAX：+81-3-3664-9660

Subsidiary (MEDRX USA INC.)

2030 Main St.,Suite 1300 Irvine, CA USA 92614
TEL : +1-949-260-4788

Subsidiary(MEDRX AUSTRALIA PTY LTD)

Suite 7, Level 7, 330 Collins Street, Melbourne, Victoria 3000, Australia.
TEL : +61-3-8689-9997

CEO (Chief Executive Officer)

Yonehiro Matsumura

Capital Fund

580 million yen (as of December 31, 2024)

Main business operation

Pharmaceutical Drug Development based on the transdermal absorption system